Tenet Healthcare (THC) EBIT (2009 - 2026)

Tenet Healthcare's EBIT history runs 18 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• In Q1 2026, EBIT rose 37.43% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $3.9 billion (up 6.83% YoY), while the FY2025 annual figure was $3.5 billion, down 41.1% from the prior year.
• EBIT came in at $1.3 billion for Q1 2026 at Tenet Healthcare, up from $853.0 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $3.3 billion in Q1 2024 to a low of $536.0 million in Q4 2022.
• A 5-year average of $917.8 million and a median of $761.0 million in 2024 frame the typical range for EBIT.
• Across the five-year window, EBIT jumped 444.78% in 2024 and sank 71.29% in 2025, its largest moves.
• Tenet Healthcare's EBIT stood at $536.0 million in 2022, then surged by 37.13% to $735.0 million in 2023, then rose by 11.7% to $821.0 million in 2024, then advanced by 3.9% to $853.0 million in 2025, then surged by 51.93% to $1.3 billion in 2026.
• According to Business Quant data, EBIT over the past three periods registered $1.3 billion, $853.0 million, and $889.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison